Market closed
Access this stock data via API
Subscribe
BioInvent International AB
0
0
0%

Financials

Cash flow

Fiscal date 2024 2023 2022 2021
Operating activities -459.0M -377.1M -54.1M -259.0M
Net income -471.5M -369.9M -50.9M -278.4M
Depreciation
Deferred taxes
StockBased compensation 5.5M 3.0M 1.8M 1.1M
Other non cash items 1.8M 1.1M
Accounts receivable -12.9M 2.4M -38.7M 23.4M
Accounts payable
Other assets liabilities 19.9M -12.5M 32.0M -6.3M
Investing activities 564.3M 59.7M -628.8M -467.5M
Capital expenditures -10.0M -13.3M -12.4M -13.3M
Net intangibles
Net acquisitions
Purchase of investments -616.5M -454.3M
Sale of investments 574.4M 73.0M
Other investing activity
Financing activities 0 31.0M 279.8M 900.8M
Long term debt issuance
Long term debt payments
Short term debt issuance
Common stock issuance 0 31.0M 279.8M 900.8M
Common stock repurchase
Common dividends
Other financing charges
End cash position 434.8M 259.5M 515.0M 910.8M
Income tax paid
Interest paid
Free cash flow -399.0M -355.0M -53.6M -259.1M
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 9 hours 25 minutes

23:34
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).